B.Sc., MBBS., FRACGP
Dr. Paul Schiavo is a global key opinion leader and pioneer in clinical regenerative medicine in Australia. He is the Founder, CEO and Medical Director of OrthoRegen, a premier regenerative medicine clinic in Australia.
Dr. Schiavo completed his medical degree at the University of Queensland in Brisbane, Australia. After his graduation, Dr. Schiavo completed his resident years at the Royal Brisbane and Women’s Hospital. He gained experience in multiple disciplines including Emergency Medicine and Orthopaedic Surgery before changing his specialty path to General Practice/Family Medicine. He continued to pursue his interest in the diagnosis and treatment of musculoskeletal conditions and sports injuries, leading him to the field of Interventional Regenerative Orthopaedic Medicine in 2013.
Dr Schiavo has a vision of bringing non-surgical regenerative medicine procedures to the community in Australia, to reduce the unnecessary high level of surgery that is taking place. He is a pioneer in medicine 4.0, the integration of digital technologies and biologics in healthcare. He is leading the field in Australia, with his innovative and evidence-based approaches to regenerative medicine and longevity medicine.
Dr Schiavo was the first physician in Australia to perform intraosseous injections of Orthobiologics for osteoarthritis, a minimally invasive procedure that delivers natural substances into the bone to stimulate healing and regeneration. He was also the first physician to use cartilage progenitor cell micro-grafting for the treatment of osteoarthritis, a cutting-edge technique that uses the patient’s own cartilage cells to repair damaged joints.
Dr Schiavo is passionate about advancing the field of regenerative medicine and improving the quality of life of his patients. He is a respected and trusted leader in Australia, who is committed to delivering the best possible outcomes for his patients. He is a true pioneer and visionary in regenerative medicine, who is making a positive impact on the world.